Disconnect between effects of mepolizumab on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps

An ACQ-6 score of less than 0.75 denotes good control and more than 1.5 denotes poor control. [...]the ACQ score is a strong predictor of future exacerbation risk.7 The mean number of asthma exacerbations requiring oral corticosteroids (OCSs) in the ensuing 12 months fell from 4 before treatment to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of allergy and clinical immunology in practice (Cambridge, MA) MA), 2020-05, Vol.8 (5), p.1714-1716
Hauptverfasser:	Chan, Rory, RuiWen Kuo, Chris, Lipworth, Brian
Format:	Artikel
Sprache:	eng
Schlagworte:	Airway management Antibodies, Monoclonal, Humanized - therapeutic use Asthma Asthma - drug therapy Chronic Disease Clinical trials Corticosteroids Endoscopy Humans Leukocytes (eosinophilic) Monoclonal antibodies Nasal Polyps - drug therapy Patients Polyps Rhinitis Rhinosinusitis Sinusitis Sinusitis - drug therapy Surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!